Skip to main navigation
Longboard

Corporate Menu

  • About
    • Overview
    • Management
    • Board of Directors
  • Our Approach
    • Overview
    • GPCR Therapies
    • Pipeline
    • Publications
  • Patients
  • Investors
    • News & Events
      • Events & Presentations
      • Press Releases
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
    • SEC Filings
    • Analyst Coverage
    • Governance
      • Overview
      • Committee Composition
    • IR Resources
      • Investor FAQs
      • Contact IR
      • Email Alerts
  • Longboard Life
  • Contact

Press Releases

March 2, 2023
Longboard Pharmaceuticals Reports Full Year 2022 Financial Results and Key Corporate Initiatives
February 23, 2023
Longboard Pharmaceuticals to Report Full Year 2022 Financial Results and Key Corporate Initiatives on March 2, 2023
February 10, 2023
Longboard Pharmaceuticals Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of Common Stock
February 7, 2023
Longboard Pharmaceuticals Announces Pricing of Public Offering of Common Stock
February 7, 2023
Longboard Pharmaceuticals Announces Commencement of Public Offering of Common Stock
©2023 Longboard Pharmaceuticals  Privacy Policy | Terms of Use
logo

Corporate Menu

  • About
    • Overview
    • Management
    • Board of Directors
  • Our Approach
    • Overview
    • GPCR Therapies
    • Pipeline
    • Publications
  • Patients
  • Investors
    • News & Events
      • Events & Presentations
      • Press Releases
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
    • SEC Filings
    • Analyst Coverage
    • Governance
      • Overview
      • Committee Composition
    • IR Resources
      • Investor FAQs
      • Contact IR
      • Email Alerts
  • Longboard Life
  • Contact